Related Experiment Video
Updated: Sep 15, 2025

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Collaborative Model of Care for Children With Medical Complexity: A Randomized Clinical Trial
Savithri Nageswaran1, Douglas Easterling2, Jamie E Skaar1
1Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Insights
The ICollab care model did not reduce hospitalizations or emergency department visits for children with medical complexity. However, it did decrease caregiver time spent coordinating care, suggesting potential benefits for family burden.
Area of Science:
- Pediatric Healthcare
- Care Coordination
- Complex Care Management
Background:
- Home health (HH) care for children with medical complexity (CMC) requires effective collaboration.
- The ICollab model was developed to enhance collaboration between hospital clinicians, HH nurses, and primary care providers.
- Evaluating ICollab's impact on hospitalizations, emergency department (ED) visits, and caregiver burden is crucial.
Purpose of the Study:
- To assess the effectiveness of the ICollab care model in improving outcomes for CMC.
- To determine if ICollab reduces hospitalizations, ED visits, and caregiver burden.
- To evaluate the impact of ICollab on healthcare provider collaboration.
Main Methods:
- A randomized controlled trial involving 96 CMC patients discharged with HH nursing.
- Patients were randomized to either the ICollab intervention group or a usual care control group for 6 months.
- Primary outcomes included hospitalization and ED visit rates; secondary outcomes included caregiver burden and collaboration metrics.
Main Results:
- No significant difference was found in the proportion of patients hospitalized between the ICollab and control groups.
- For hospitalized patients, the ICollab group showed a lower hospitalization rate and fewer hospital days.
- Caregiver time spent coordinating care was significantly reduced in the ICollab group, but other secondary and intermediate outcomes showed no difference.
Conclusions:
- The ICollab model did not meet its primary hypothesis of reducing overall hospitalizations or ED visits.
- ICollab demonstrated a benefit in reducing caregiver time dedicated to care coordination.
- Further research with larger studies is needed to fully ascertain the effectiveness of the ICollab model.
Background And Objectives:
Improving home health (HH) care for children with medical complexity (CMC) is critical. We developed ICollab, a care model involving collaboration between a children's hospital's complex care clinicians, HH nurses, and primary care providers. We sought to evaluate ICollab's effectiveness in reducing hospitalizations, emergency department (ED) visits, and caregiver burden and improving health care provider collaboration.
Methods:
In this randomized controlled trial (November 2019 to February 2023) in North Carolina, 96 CMC discharged with HH nursing were randomized to receive ICollab with usual care (intervention; n = 50) vs usual care only (control; n = 46) for 6 months. Outcomes were hospitalization rate, hospital days, days to hospitalization, ED visit rate, and days to ED visit (primary); caregiver time coordinating care and Impact on Family Scale (secondary); and measures of health care provider collaboration and satisfaction with care (intermediate).
Results:
Between the 2 arms, there was no difference in proportion with at least 1 hospitalization (43% vs 36%; P = .47). In children with at least 1 hospitalization, intervention vs control group had lower hospitalization rate (280/100 vs 840/100 child-years; P = .01) and hospital days (4.8% vs 13%; P = .01). There was no difference between the arms in ED visit metrics. There was a significant reduction in time spent coordinating care (1-4 scale), with ICollab (3.23) vs control (3.68; P = .02). There were no group differences in other secondary or intermediate outcomes.
Conclusions:
Contrary to our hypothesis, ICollab did not reduce hospitalization or ED visit metrics. ICollab reduced caregiver time coordinating care but had no effect on other outcomes. Larger studies are necessary to evaluate ICollab's effectiveness.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Chronic Kidney Disease III: Interprofessional Care
Chronic Pancreatitis II: Collaborative Care
Assessment:
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...